In Vitro Killing Experimental Platform from InnoModels Biotechnology
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-09-25 16:44
- Views:
(Summary description)In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In Vitro Killing Experimental Platform from InnoModels Biotechnology
(Summary description)In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-09-25 16:44
- Views:
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
Platform Overview
InnoModels' in vitro killing platform is a comprehensive experimental platform integrating multiple advanced technologies, focusing on simulating cell-cell interactions in an in vitro environment, especially the killing effect of immune cells on tumor cells. The platform ensures the accuracy and reproducibility of the experimental results by precisely controlling the experimental conditions, such as temperature, humidity and atmosphere. Meanwhile, it supports the application of multiple cell types, including tumor cells, primary cells, etc., providing researchers with a wide range of possibilities in different fields.
Platform Features
1. **Highly controllable experimental environment**: The in vitro killing experimental platform of InnoModels Biotechnology is able to precisely regulate the experimental conditions and reduce the interference of external factors to ensure the accuracy of the experimental results.
2. **Multiple cell types support**: The platform supports the application of multiple cell types, enabling researchers to carry out a wide range of studies in different fields and meet diversified experimental needs.
3. **Real-time monitoring and data analysis**: During the experiment, the platform is able to monitor the cell status and response in real-time, as well as record and analyze the data, providing researchers with comprehensive experimental results.
4. **Advanced automation technology**: Automation technology is used to optimize the experimental process, reduce experimental errors, and improve the reliability and efficiency of experiments.
Core Technology and Application
One of the core technologies of the platform is the PBMC-tumor cell co-culture killing model. The model achieves precise distinction between effector cells (immune cells) and target cells (tumor cells) by mixing cultured peripheral blood single nucleated cells (PBMCs) and tumor cells, and using CFSE-labeled tumor cells and CD45-labeled immune cells. The killing of target cells was verified by flow cytometry, which effectively reduces the influence of immune cell proliferation and apoptosis on the test results, and achieves an accurate assessment of killing.
Application Areas
The in vitro killing experimental platform of InnoModels Biotechnology has been widely used in many fields:
1. **Drug Screening**: Researchers can utilize the platform to conduct large-scale drug screening to assess the killing effect of drugs on cells, providing important data support for new drug discovery.
2. **Toxicity assessment**: It is used to assess the toxicity level of compounds or drugs, providing key information for safety assessment during drug development.
3. **Immunotherapy Research**: When researching immunotherapy, the platform can be used to assess the killing effect of immune cells on tumor cells, providing an important reference for the development and optimization of immunotherapy.
4. **Personalized Medicine**: Tailor-made treatment plans based on individual patient's immune response to improve therapeutic effects and promote the development of individualized medicine.
Company Background and Vision
Ltd. was co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion and Shanghai Jiao Tong University Institute of Immunology. The company has always been committed to promoting technological innovation and providing scientists with advanced experimental tools to help research and development of oncology and tumor immunotherapy. Its in vitro killing experimental platform, as one of the company's important achievements, not only provides strong support for drug discovery companies and translational medicine researchers, but also brings more therapeutic hope to tumor patients.
In the future, InnoModels Biotechnology will continue to uphold the attitude of never compromising on quality, adhere to the ethical bottom line of scientists, and dedicate itself to providing more advanced and reliable experimental platforms and technical support in the field of life science research and drug development, and promoting the continuous progress and development of the scientific field.
- Tel 15010000264
- E-mail limy@imodels.tech
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company